

ACCÈS RAPIDE AUX LIENS
The glyoxal pathway plays a role in the detoxification of glucose degradation products (GDP). Glyoxalase I and Gyloxalase II (also designated hydroxyacyl glutathione hydrolase or HAGH) are members of the Gyloxalase family. The Gyloxalase II enzyme is a thiolesterase that catalyzes the hydrolysis of S-D-lactoyl-glutathione to form reduced glutathione and D-lactic acid. It exists only as a monomer and binds two zinc ions per subunit. Glyoxalase II contains 260 amino acids. It is detected in the mitochondria and cytosol of mammals. Both Glyoxalase I and Gyloxalase II are detected at a higher activity level in breast cancer tissues than with matched unaffected tissues. This suggests that glyoxalase inhibitor drugs may be effective in the treatment of cancer.
Informations pour la commande
| Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Anticorps Glyoxalase II (C-6) | sc-271663 | 200 µg/ml | $316.00 | |||
Glyoxalase II (C-6): m-IgG Fc BP-HRP Kit | sc-537676 | 200 µg Ab; 10 µg BP | $354.00 | |||
Glyoxalase II (C-6): m-IgGκ BP-HRP Kit | sc-535017 | 200 µg Ab; 40 µg BP | $354.00 | |||
Glyoxalase II (C-6): m-IgG1 BP-HRP Kit | sc-545300 | 200 µg Ab; 20 µg BP | $354.00 | |||
Glyoxalase II (C-6) peptide neutralisant | sc-271663 P | 100 µg/0.5 ml | $68.00 |